{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Sertkaya H"],"funding":["Medical Research Council","Wellcome Trust"],"pagination":["147-157"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8517000"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["23"],"pubmed_abstract":["The antiviral protein ZAP binds CpG dinucleotides in viral RNA to inhibit replication. This has likely led to the CpG suppression observed in many RNA viruses, including retroviruses. Sequences added to retroviral vector genomes, such as internal promoters, transgenes, or regulatory elements, substantially increase CpG abundance. Because these CpGs could allow retroviral vector RNA to be targeted by ZAP, we analyzed whether it restricts vector production, transduction efficiency, and transgene expression. Surprisingly, even though CpG-high HIV-1 was efficiently inhibited by ZAP in HEK293T cells, depleting ZAP did not substantially increase lentiviral vector titer using several packaging and genome plasmids. ZAP overexpression also did not inhibit lentiviral vector titer. In addition, decre"],"journal":["Molecular therapy. Methods & clinical development"],"pubmed_title":["Minimal impact of ZAP on lentiviral vector production and transduction efficiency."],"pmcid":["PMC8517000"],"funding_grant_id":["MC_PC_15068","1939180","MR/S000844/1","207442/Z/17/Z","MR/M019756/1","106223/Z/14/Z"],"pubmed_authors":["Hidalgo L","Kmiec D","Malim MH","Swanson CM","Sertkaya H","Ficarelli M","Ali S","Wilson H","Neil SJD","Parker H","Signell AW","Vink CA"],"additional_accession":[]},"is_claimable":false,"name":"Minimal impact of ZAP on lentiviral vector production and transduction efficiency.","description":"The antiviral protein ZAP binds CpG dinucleotides in viral RNA to inhibit replication. This has likely led to the CpG suppression observed in many RNA viruses, including retroviruses. Sequences added to retroviral vector genomes, such as internal promoters, transgenes, or regulatory elements, substantially increase CpG abundance. Because these CpGs could allow retroviral vector RNA to be targeted by ZAP, we analyzed whether it restricts vector production, transduction efficiency, and transgene expression. Surprisingly, even though CpG-high HIV-1 was efficiently inhibited by ZAP in HEK293T cells, depleting ZAP did not substantially increase lentiviral vector titer using several packaging and genome plasmids. ZAP overexpression also did not inhibit lentiviral vector titer. In addition, decre","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Dec","modification":"2025-05-18T10:37:50.904Z","creation":"2025-05-18T10:37:50.904Z"},"accession":"S-EPMC8517000","cross_references":{"pubmed":["34703838"],"doi":["10.1016/j.omtm.2021.08.008"]}}